Correlations between ceruloplasmin, lactoferrin and myeloperoxidase in meconium

Journal of Trace Elements in Medicine and Biology

Volumn 43, Issue , 2017, Pages 58-62

  Skarżyńska, Ewa ^a   Żytyńska Daniluk, Joanna ^b   Lisowska Myjak, Barbara ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b Clinical Hospital of Interior   (Poland)

Author keywords

Ceruloplasmin; Lactoferrin; Meconium; Myeloperoxidase

Indexed keywords

CERULOPLASMIN; LACTOFERRIN; MYELOPEROXIDASE; BIOLOGICAL MARKER; PEROXIDASE; PROTEIN BINDING;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MECONIUM; NEWBORN; NORMAL HUMAN; OXIDATIVE STRESS; PERINATAL DEVELOPMENT; PILOT STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; UTERUS; ADULT; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; METABOLISM; OXIDATION REDUCTION REACTION; PREGNANCY;

ADULT; BIOMARKERS; CERULOPLASMIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LACTOFERRIN; MECONIUM; OXIDATION-REDUCTION; PEROXIDASE; PREGNANCY; PROTEIN BINDING;

EID: 85008215941     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2016.11.007     Document Type: Article

References (26)

1. Thompson, L.P., Al-Hasan, Y., Impact of oxidative stress in fetal programming. J. Pregnancy, 2012, 1–8 Article ID 582748.
2. Dennery, P.A., Oxidative stress in development: nature or nurture?. Free Radic. Biol. Med. 49:7 (2010), 1147–1151.
3. Buonocore, G., Perrone, S., Biomarkers of oxidative stress in the fetus and newborn. Hematology 2:10 (2006), 103–107.
4. Sokolov, A.V., Zakharova, E.T., Kostevich, V.A., Samygina, V.R., Vasilyev, V.B., Lactoferrin, myeloperoxidase, and ceruloplasmin: complementary gearwheels cranking physiological and pathological processes. Biometals 27 (2014), 815–828.
5. Sokolov, A.V., Kostevich, V.A., Zakharova, E.T., Samygina, V.R., Panasenko, O.M., Vasilyev, V.B., Interaction of ceruloplasmin with eosinophil peroxidase as compared to its interplay with myeloperoxidase: reciprocal effect on enzymatic properties. Free Radic. Res. 49:6 (2015), 800–811.
6. Vasilyev, V.B., Interactions of caeruloplasmin with other proteins participating in inflammation. Biochem. Soc. Trans. 38:4 (2010), 947–951.
7. Sokolov, A.V., Ageeva, K.V., Pulina, M.O., Zakharova, E.T., Vasilyev, V.B., Effect of lactoferrin on oxidative features of ceruloplasmin. Biometals 22:3 (2009), 521–529.
8. Pulina, M.O., Zakharova, E.T., Sokolov, A.V., Shavlovski, M.M., Bass, M.G., Solovyov, K.V., Kokryakov, V.N., Vasilyev, V.B., Studies of the ceruloplasmin-lactoferrin complex. Biochem. Cell Biol. 80:1 (2002), 35–39.
9. Shukla, N., Maher, J., Masters, J., Angelini, G.D., Jeremy, J.Y., Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor?. Atherosclerosis 187:2 (2006), 238–250.
10. Bielli, P., Calabrese, L., Structure to function relationships in ceruloplasmin: a ‘moonlighting’ protein. Cell. Mol. Life Sci. 59:9 (2002), 1413–1427.
11. Hordyjewska, A., Popiołek, Ł., Kocot, J., The many “faces” of copper in medicine and treatment. Biometals 27:4 (2014), 611–621.
12. Arnhold, J., Flemmig, J., Human myeloperoxidase in innate and acquired immunity. Arch. Biochem. Biophys. 500:1 (2010), 92–106.
13. Prokopowicz, Z., Marcinkiewicz, J., Katz, D.R., Chain, B.M., Neutrophil myeloperoxidase: soldier and statesman. Arch. Immunol. Ther. Exp. 60:1 (2012), 43–54.
14. Legrand, D., Elass, E., Carpentier, M., Mazurier, J., Lactoferrin: a modulator of immune and inflammatory responses. Cell. Mol. Life Sci. 62:22 (2005), 2549–2559.
15. Maneva, A., Taleva, B., Maneva, L., Lactoferrin-protector against oxidative stress and regulator of glycolysis in human erythrocytes. Z. Naturforsch. 58:3–4 (2003), 256–262.
16. Chapman, A.L., Mocatta, T.J., Shiva, S., Seidel, A., Chen, B., Khalilova, I., Paumann-Page, M.E., Jameson, G.N., Winterbourn, C.C., Kettle, A.J., Ceruloplasmin is an endogenous inhibitor of myeloperoxidase. J. Biol. Chem. 288:9 (2013), 6465–6477.
17. Segelmark, M., Persson, B., Hellmark, T., Wieslander, J., Binding and inhibition of myeloperoxidase (MPO): a major function of ceruloplasmin?. Clin. Exp. Immunol. 108:1 (1997), 167–174.
18. Peterson, C.G., Eklund, E., Taha, Y., Raab, Y., Carlson, M., A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. Am. J. Gastroenterol. 97:7 (2002), 1755–1762.
19. Saiki, T., Myeloperoxidase concentrations in the stool as a new parameter of inflammatory bowel disease. Kurume Med. J. 45:1 (1998), 69–73.
20. Kopylov, U., Rosenfeld, G., Bressler, B., Seidman, E., Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease. Inflamm. Bowel Dis. 20:4 (2014), 742–756.
21. Bakhautdin, B., Febbraio, M., Goksoy, E., de la Motte, C.A., Gulen, M.F., Childers, E.P., Hazen, S.L., Li, X., Fox, P.L., Protective role of macrophage-derived ceruloplasmin in inflammatory bowel disease. Gut 62:2 (2013), 209–219.
22. Bentwood, B.J., Henson, P.M., The sequential release of granule constituents from human neutrophils. J. Immunol. 124:2 (1980), 855–862.
23. Calkins, K., Devaskar, S.U., Fetal origins of adult disease. Curr. Probl. Pediatr. Adolesc. Health Care 41:6 (2011), 158–176.
24. Ostrea, E.M., Bielawski, D.M., Posecion, N.C., Meconium analysis to detect fetal exposure to neurotoxicants. Arch. Dis. Child. 91:8 (2006), 628–629.
25. Díaz-Castro, J., Florido, J., Kajarabille, N., Prados, S., de Paco, C., Ocon, O., Pulido-Moran, M., Ochoa, J.J., A new approach to oxidative stress and inflammatory signaling during labour in healthy mothers and neonates. Oxid. Med. Cell. Longev., 2015, 1–8 Article ID 178536.
26. Giuffrè, M., Rizzo, M., Scaturro, G., Pitruzzella, A., Marino Gammazza, A., Cappello, F., Corsello, G., Li Volti, G., Oxidative stress markers at birth: analyses of a neonatal population. Acta Histochem. 117:4-5 (2015), 486–491.